(KBH) KB Home - Ratings and Ratios
Homes, Townhomes, Condominiums, Mortgages, Insurance
Dividends
| Dividend Yield | 1.56% |
| Yield on Cost 5y | 3.13% |
| Yield CAGR 5y | 22.64% |
| Payout Consistency | 88.7% |
| Payout Ratio | 14.0% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 35.9% |
| Value at Risk 5%th | 56.4% |
| Relative Tail Risk | -4.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.60 |
| Alpha | -32.22 |
| CAGR/Max DD | 0.70 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.360 |
| Beta | 0.626 |
| Beta Downside | 0.333 |
| Drawdowns 3y | |
|---|---|
| Max DD | 43.66% |
| Mean DD | 14.24% |
| Median DD | 8.48% |
Description: KBH KB Home November 08, 2025
KB Home (NYSE:KBH) is a U.S. homebuilder that structures its business across four geographic segments-West Coast, Southwest, Central, and Southeast-constructing and selling attached and detached single-family homes, townhomes, and condominiums. Its primary customer base includes first-time, move-up, and active-adult buyers, and the firm augments revenue with mortgage-originating, insurance, and title-service offerings.
As of its 2023 fiscal year, KB Home delivered roughly 10,200 homes, generating an average selling price of about $352 million, and reported a backlog of approximately 13,000 units-metrics that reflect both the company’s scale and exposure to housing-market cycles. The builder’s performance is tightly linked to macro drivers such as the Federal Reserve’s interest-rate policy (which directly affects mortgage rates) and regional labor-cost trends in its key markets (California, Texas, Florida). Additionally, the homebuilding sector’s inventory-to-sales ratio, currently hovering near 5 months nationally, serves as a leading indicator of demand pressure for KB Home’s price-sensitive buyer segments.
For a deeper, data-driven assessment of KB Home’s valuation dynamics, you may find ValueRay’s analytical platform worth exploring.
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (517.9m TTM) > 0 and > 6% of Revenue (6% = 392.5m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA 1.03pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 94.62% (prev 84.54%; Δ 10.08pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 394.5m <= Net Income 517.9m (YES >=105%, WARN >=100%) |
| Net Debt (1.61b) to EBITDA (688.8m) ratio: 2.34 <= 3.0 (WARN <= 3.5) |
| Current Ratio 17.90 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (67.7m) change vs 12m ago -11.61% (target <= -2.0% for YES) |
| Gross Margin 19.89% (prev 41.13%; Δ -21.24pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 94.63% (prev 96.55%; Δ -1.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.06 (EBITDA TTM 688.8m / Interest Expense TTM 92.1m) >= 6 (WARN >= 3) |
Altman Z'' 9.74
| (A) 0.89 = (Total Current Assets 6.56b - Total Current Liabilities 366.2m) / Total Assets 6.99b |
| (B) 0.51 = Retained Earnings (Balance) 3.54b / Total Assets 6.99b |
| (C) 0.09 = EBIT TTM 650.6m / Avg Total Assets 6.91b |
| (D) 1.56 = Book Value of Equity 3.61b / Total Liabilities 2.31b |
| Total Rating: 9.74 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.33
| 1. Piotroski 5.0pt |
| 2. FCF Yield 6.07% |
| 3. FCF Margin 5.35% |
| 4. Debt/Equity 0.42 |
| 5. Debt/Ebitda 2.34 |
| 6. ROIC - WACC (= 2.54)% |
| 7. RoE 12.32% |
| 8. Rev. Trend -6.72% |
| 9. EPS Trend -49.70% |
What is the price of KBH shares?
Over the past week, the price has changed by +0.77%, over one month by +5.69%, over three months by +2.86% and over the past year by -21.39%.
Is KBH a buy, sell or hold?
- Strong Buy: 3
- Buy: 1
- Hold: 8
- Sell: 0
- Strong Sell: 2
What are the forecasts/targets for the KBH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 64.7 | 0.6% |
| Analysts Target Price | 64.7 | 0.6% |
| ValueRay Target Price | 76.5 | 19% |
KBH Fundamental Data Overview December 03, 2025
P/E Trailing = 9.0211
P/E Forward = 10.3734
P/S = 0.635
P/B = 1.0676
P/EG = 0.63
Beta = 1.4
Revenue TTM = 6.54b USD
EBIT TTM = 650.6m USD
EBITDA TTM = 688.8m USD
Long Term Debt = 1.69b USD (from longTermDebt, last quarter)
Short Term Debt = 250.0m USD (from shortLongTermDebt, last quarter)
Debt = 1.94b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.61b USD (from netDebt column, last quarter)
Enterprise Value = 5.77b USD (4.15b + Debt 1.94b - CCE 330.6m)
Interest Coverage Ratio = 7.06 (Ebit TTM 650.6m / Interest Expense TTM 92.1m)
FCF Yield = 6.07% (FCF TTM 349.8m / Enterprise Value 5.77b)
FCF Margin = 5.35% (FCF TTM 349.8m / Revenue TTM 6.54b)
Net Margin = 7.92% (Net Income TTM 517.9m / Revenue TTM 6.54b)
Gross Margin = 19.89% ((Revenue TTM 6.54b - Cost of Revenue TTM 5.24b) / Revenue TTM)
Gross Margin QoQ = 18.47% (prev 19.48%)
Tobins Q-Ratio = 0.83 (Enterprise Value 5.77b / Total Assets 6.99b)
Interest Expense / Debt = 1.37% (Interest Expense 26.6m / Debt 1.94b)
Taxrate = 23.32% (33.4m / 143.2m)
NOPAT = 498.9m (EBIT 650.6m * (1 - 23.32%))
Current Ratio = 17.90 (Total Current Assets 6.56b / Total Current Liabilities 366.2m)
Debt / Equity = 0.42 (Debt 1.94b / totalStockholderEquity, last quarter 4.68b)
Debt / EBITDA = 2.34 (Net Debt 1.61b / EBITDA 688.8m)
Debt / FCF = 4.61 (Net Debt 1.61b / FCF TTM 349.8m)
Total Stockholder Equity = 4.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.41% (Net Income 517.9m / Total Assets 6.99b)
RoE = 12.32% (Net Income TTM 517.9m / Total Stockholder Equity 4.20b)
RoCE = 11.03% (EBIT 650.6m / Capital Employed (Equity 4.20b + L.T.Debt 1.69b))
RoIC = 8.54% (NOPAT 498.9m / Invested Capital 5.84b)
WACC = 6.00% (E(4.15b)/V(6.10b) * Re(8.32%) + D(1.94b)/V(6.10b) * Rd(1.37%) * (1-Tc(0.23)))
Discount Rate = 8.32% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -8.28%
[DCF Debug] Terminal Value 69.23% ; FCFE base≈318.7m ; Y1≈209.2m ; Y5≈95.7m
Fair Price DCF = 27.71 (DCF Value 1.79b / Shares Outstanding 64.8m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -49.70 | EPS CAGR: -44.43% | SUE: -4.0 | # QB: 0
Revenue Correlation: -6.72 | Revenue CAGR: -0.88% | SUE: 0.56 | # QB: 0
EPS next Quarter (2026-02-28): EPS=0.89 | Chg30d=-0.155 | Revisions Net=-4 | Analysts=7
EPS next Year (2026-11-30): EPS=6.13 | Chg30d=-0.313 | Revisions Net=-2 | Growth EPS=-4.2% | Growth Revenue=-8.3%
Additional Sources for KBH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle